Clinical Study
Induction Chemotherapy in Locally Advanced Pharyngolaryngeal Cancers with Stridor: Is It Feasible and Safe?
Table 2
Baseline characteristics.
| | Patient | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| | Age in years | 53 | 45 | 45 | 42 | 71 | 47 | 66 | 55 | | Sex | M | F | M | F | M | F | M | M | | Comorbidity | none | none | none | none | IHD | none | none | none | | Primary site | Supra glottis | PFS | Post cricoid | PFS | Supra glottis | PFS | Supra glottis | Supra glottis | | T stage | 3 | 4a | 3 | 4a | 3 | 3 | 3 | 4 | | Minor thyroid cartilage invasion | No | Yes | No | Yes | No | No | No | yes | | N stage | 0 | 0 | 3 | 1 | 2c | 2c | 0 | 2a | | Stage | III | IVa | IVb | IVa | IVa | IVa | III | IVa | | BMI (Kg/) | 22 | 15 | 27 | 18 | 24 | 18 | 19 | 22 | | ECOG performance status | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | | Haemoglobin (g/dL) | 10 | 9.6 | 12 | 11.5 | 13 | 11 | 12 | 13 | | Albumin (mg/dL) | 4 | 3 | 4 | 4.2 | 3.7 | 3.8 | 3.6 | 3.7 |
|
|
IHD: ischemic heart disease, PFS: pyriform sinus, M: male, F: female.
|
